Hybrid Capture 2 Is as Effective as PCR Testing for High-Risk Human Papillomavirus in Head and Neck Cancers
Applied Immunohistochemistry and Molecular Morphology - United States
doi 10.1097/pdm.0000000000000036
Full Text
Open PDFAbstract
Available in full text
Date
April 1, 2015
Authors
Publisher
Ovid Technologies (Wolters Kluwer Health)